These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11393093)

  • 1. Targeting cytolytic samples for quality control.
    Bibbo M; Hawthorne C
    Acta Cytol; 2001; 45(3):486-8. PubMed ID: 11393093
    [No Abstract]   [Full Text] [Related]  

  • 2. S.I.L. and consistency.
    Colgan TJ
    Int J Gynecol Pathol; 1992; 11(2):161. PubMed ID: 1582749
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving the adequacy of Pap smears.
    Baker RM
    Am Fam Physician; 1989 Jun; 39(6):109-14. PubMed ID: 2729036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bethesda 2001.
    Smith JH
    Cytopathology; 2002 Feb; 13(1):4-10. PubMed ID: 11985563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings.
    Stoler MH
    JAMA; 2002 Apr; 287(16):2140-1. PubMed ID: 11966390
    [No Abstract]   [Full Text] [Related]  

  • 6. Inadequate cervical smear: what do we do?
    Phadnis SV; Doshi JS; Ogunnaike OO; Padwick ML; Sanusi FA
    Acta Obstet Gynecol Scand; 2005 May; 84(5):486-8. PubMed ID: 15842215
    [No Abstract]   [Full Text] [Related]  

  • 7. Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC).
    Duska LR
    Gynecol Oncol; 2009 Sep; 114(3):381-2. PubMed ID: 19647129
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we report cervical smears lacking endocervical component as unsatisfactory?
    Sidawy MK; Tabbara SO; Silverberg SG
    Diagn Cytopathol; 1992; 8(6):567-70. PubMed ID: 1468332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guideline for managing suspect and positive cytologic smears of the uterine cervix (revised form, version 2.4)].
    Arbeitsgruppe "Guideline Zervixabstrich"
    Gynakol Geburtshilfliche Rundsch; 2005 Jan; 45(1):44-55. PubMed ID: 15655885
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of cervical cytodiagnosis and histopathology--an exercise in quality control.
    Kealy WF
    Ir J Med Sci; 1986 Nov; 155(11):381-8. PubMed ID: 3804671
    [No Abstract]   [Full Text] [Related]  

  • 11. ACOG releases guidelines on cervical cytology screening.
    Ressel GW;
    Am Fam Physician; 2003 Nov; 68(10):2081, 2084. PubMed ID: 14655818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quality of conventional PAP smears. Quality assessment and motivation for improvement].
    Regitnig P; Nader A; Wiener H
    Pathologe; 2012 Jul; 33(4):293-300. PubMed ID: 22569927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economics of screening.
    Stewart CJ
    Cytopathology; 1997 Jun; 8(3):211. PubMed ID: 9202898
    [No Abstract]   [Full Text] [Related]  

  • 14. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical screening: what is the point?
    Robertson J; Woodend B
    Lancet; 1995 Jul; 346(8969):245; author reply 246-7. PubMed ID: 7616812
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies.
    Dodd LG; Sneige N; Villarreal Y; Fanning CV; Staerkel GA; Caraway NP; Silva EG; Katz RL
    Diagn Cytopathol; 1993; 9(2):138-44. PubMed ID: 8513706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Herbert A; Johnson J; Patnick J
    Cytopathology; 1995 Oct; 6(5):301-3. PubMed ID: 8785367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Déjà vu in pap testing: return of the 5% false-negative fraction and the zero-error rate.
    Renshaw AA
    Diagn Cytopathol; 2002 Jun; 26(6):343-4. PubMed ID: 12112821
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the sampling sequence on the quality of Papanicolaou smear.
    Rahnama P; Faghihzadeh S; Ziaei S
    Int J Gynecol Cancer; 2005; 15(1):66-9. PubMed ID: 15670299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.